

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cobalamin metabolic process (GO:0009235) | 8.95651198 |
| 2 | regulation of phospholipase A2 activity (GO:0032429) | 8.63090440 |
| 3 | transcytosis (GO:0045056) | 8.42892797 |
| 4 | synaptic vesicle maturation (GO:0016188) | 7.96666319 |
| 5 | intestinal absorption (GO:0050892) | 7.90848901 |
| 6 | cholesterol catabolic process (GO:0006707) | 7.75213179 |
| 7 | sterol catabolic process (GO:0016127) | 7.75213179 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.68550032 |
| 9 | negative regulation of digestive system process (GO:0060457) | 7.15674935 |
| 10 | glutamate secretion (GO:0014047) | 7.04936999 |
| 11 | glycolipid catabolic process (GO:0019377) | 6.80033199 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.65515962 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 6.58443104 |
| 14 | cysteine metabolic process (GO:0006534) | 6.55217065 |
| 15 | membrane lipid catabolic process (GO:0046466) | 6.44799208 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 6.33075792 |
| 17 | branched-chain amino acid catabolic process (GO:0009083) | 6.23310572 |
| 18 | valine metabolic process (GO:0006573) | 6.01779467 |
| 19 | proline biosynthetic process (GO:0006561) | 5.86623001 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 5.82761623 |
| 21 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.69603098 |
| 22 | * protein retention in ER lumen (GO:0006621) | 5.69025927 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 5.59644600 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 5.59644600 |
| 25 | ceramide catabolic process (GO:0046514) | 5.54052838 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.52775822 |
| 27 | * maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.47764584 |
| 28 | neurotransmitter secretion (GO:0007269) | 5.47274659 |
| 29 | branched-chain amino acid metabolic process (GO:0009081) | 5.45473133 |
| 30 | axon ensheathment in central nervous system (GO:0032291) | 5.43508622 |
| 31 | central nervous system myelination (GO:0022010) | 5.43508622 |
| 32 | leukotriene biosynthetic process (GO:0019370) | 5.39319393 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 5.38168420 |
| 34 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.32317124 |
| 35 | neutrophil mediated immunity (GO:0002446) | 5.23298305 |
| 36 | locomotory exploration behavior (GO:0035641) | 5.15376813 |
| 37 | sodium ion export (GO:0071436) | 5.14700259 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 5.09068403 |
| 39 | cellular modified amino acid catabolic process (GO:0042219) | 5.04447497 |
| 40 | neuronal ion channel clustering (GO:0045161) | 4.96968124 |
| 41 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.84731674 |
| 42 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.83635224 |
| 43 | mitochondrial calcium ion transport (GO:0006851) | 4.81459584 |
| 44 | zinc ion transport (GO:0006829) | 4.73605407 |
| 45 | cerebellar granule cell differentiation (GO:0021707) | 4.65950930 |
| 46 | positive regulation of nuclease activity (GO:0032075) | 4.65029071 |
| 47 | serine family amino acid biosynthetic process (GO:0009070) | 4.63138518 |
| 48 | neuronal action potential propagation (GO:0019227) | 4.58023464 |
| 49 | protein maturation by protein folding (GO:0022417) | 4.50080554 |
| 50 | aspartate family amino acid catabolic process (GO:0009068) | 4.48524551 |
| 51 | antibacterial humoral response (GO:0019731) | 4.46741072 |
| 52 | vocalization behavior (GO:0071625) | 4.45085256 |
| 53 | exploration behavior (GO:0035640) | 4.42533675 |
| 54 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.39626325 |
| 55 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.36907967 |
| 56 | homocysteine metabolic process (GO:0050667) | 4.36526477 |
| 57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.35690853 |
| 58 | signal peptide processing (GO:0006465) | 4.33012263 |
| 59 | neurotransmitter transport (GO:0006836) | 4.32535181 |
| 60 | positive regulation of heat generation (GO:0031652) | 4.30140686 |
| 61 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.29180418 |
| 62 | cellular response to unfolded protein (GO:0034620) | 4.26841562 |
| 63 | potassium ion homeostasis (GO:0055075) | 4.26010134 |
| 64 | intestinal epithelial cell development (GO:0060576) | 4.24731069 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.23853763 |
| 66 | regulation of nuclease activity (GO:0032069) | 4.22749937 |
| 67 | 4-hydroxyproline metabolic process (GO:0019471) | 4.14947296 |
| 68 | antimicrobial humoral response (GO:0019730) | 4.14056180 |
| 69 | arachidonic acid secretion (GO:0050482) | 4.12511501 |
| 70 | icosanoid secretion (GO:0032309) | 4.12511501 |
| 71 | regulation of fever generation (GO:0031620) | 4.09545214 |
| 72 | * response to endoplasmic reticulum stress (GO:0034976) | 4.06480293 |
| 73 | cellular response to topologically incorrect protein (GO:0035967) | 4.05469818 |
| 74 | ER-nucleus signaling pathway (GO:0006984) | 4.04791474 |
| 75 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.04605104 |
| 76 | glutamine metabolic process (GO:0006541) | 4.02697808 |
| 77 | regulation of synapse maturation (GO:0090128) | 4.01252012 |
| 78 | GDP-mannose metabolic process (GO:0019673) | 4.01085433 |
| 79 | myeloid leukocyte mediated immunity (GO:0002444) | 4.00213337 |
| 80 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.99995962 |
| 81 | L-amino acid import (GO:0043092) | 3.99873829 |
| 82 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.99342234 |
| 83 | potassium ion import (GO:0010107) | 3.98446219 |
| 84 | regulation of synapse structural plasticity (GO:0051823) | 3.96772875 |
| 85 | steroid catabolic process (GO:0006706) | 3.96646933 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.94539650 |
| 87 | dendritic spine morphogenesis (GO:0060997) | 3.94146733 |
| 88 | postsynaptic membrane organization (GO:0001941) | 3.94077380 |
| 89 | proline metabolic process (GO:0006560) | 3.93074119 |
| 90 | positive regulation of membrane potential (GO:0045838) | 3.92452787 |
| 91 | regulation of neurotransmitter levels (GO:0001505) | 3.90122946 |
| 92 | regulation of neurotransmitter secretion (GO:0046928) | 3.87665670 |
| 93 | synaptic transmission, glutamatergic (GO:0035249) | 3.87579358 |
| 94 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.86923464 |
| 95 | coenzyme catabolic process (GO:0009109) | 3.83441337 |
| 96 | protein localization to synapse (GO:0035418) | 3.81894164 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.81852545 |
| 98 | amino acid import (GO:0043090) | 3.78020795 |
| 99 | L-serine metabolic process (GO:0006563) | 3.75108917 |
| 100 | regulation of ARF protein signal transduction (GO:0032012) | 3.74001734 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.72824062 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 3.72727989 |
| 103 | synaptic vesicle endocytosis (GO:0048488) | 3.70391890 |
| 104 | creatine metabolic process (GO:0006600) | 3.69964627 |
| 105 | positive regulation of dendritic spine development (GO:0060999) | 3.68931593 |
| 106 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.67751942 |
| 107 | regulation of synaptic plasticity (GO:0048167) | 3.64276769 |
| 108 | COPII vesicle coating (GO:0048208) | 3.64013097 |
| 109 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.63450028 |
| 110 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.61931926 |
| 111 | sphingolipid catabolic process (GO:0030149) | 3.61149940 |
| 112 | auditory behavior (GO:0031223) | 3.60760842 |
| 113 | regulation of vesicle fusion (GO:0031338) | 3.60658482 |
| 114 | tetrapyrrole metabolic process (GO:0033013) | 3.60122998 |
| 115 | serine family amino acid metabolic process (GO:0009069) | 3.60055352 |
| 116 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.56255567 |
| 117 | L-phenylalanine catabolic process (GO:0006559) | 3.56255567 |
| 118 | neuron-neuron synaptic transmission (GO:0007270) | 3.55100842 |
| 119 | innate immune response in mucosa (GO:0002227) | 3.54877469 |
| 120 | establishment of mitochondrion localization (GO:0051654) | 3.54202913 |
| 121 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.53855020 |
| 122 | glutamate receptor signaling pathway (GO:0007215) | 3.51218002 |
| 123 | digestive system process (GO:0022600) | 3.51194544 |
| 124 | gamma-aminobutyric acid transport (GO:0015812) | 3.50680317 |
| 125 | neuron cell-cell adhesion (GO:0007158) | 3.50046566 |
| 126 | regulation of neurotransmitter transport (GO:0051588) | 3.50013387 |
| 127 | layer formation in cerebral cortex (GO:0021819) | 3.49985571 |
| 128 | regulation of postsynaptic membrane potential (GO:0060078) | 3.49847909 |
| 129 | cell migration in hindbrain (GO:0021535) | 3.49440203 |
| 130 | positive regulation of neurotransmitter transport (GO:0051590) | 3.49213448 |
| 131 | ER overload response (GO:0006983) | 3.48011865 |
| 132 | cell differentiation in hindbrain (GO:0021533) | 3.47128371 |
| 133 | cellular sodium ion homeostasis (GO:0006883) | 3.46765000 |
| 134 | response to unfolded protein (GO:0006986) | 3.46473854 |
| 135 | mitochondrion distribution (GO:0048311) | 3.45358973 |
| 136 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.44014398 |
| 137 | cell communication by electrical coupling (GO:0010644) | 3.40224902 |
| 138 | L-phenylalanine metabolic process (GO:0006558) | 3.38203111 |
| 139 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38203111 |
| 140 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.37869362 |
| 141 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.37117472 |
| 142 | fatty acid derivative transport (GO:1901571) | 3.35126757 |
| 143 | icosanoid transport (GO:0071715) | 3.35126757 |
| 144 | transmission of nerve impulse (GO:0019226) | 3.34473565 |
| 145 | leukotriene metabolic process (GO:0006691) | 3.33466975 |
| 146 | response to topologically incorrect protein (GO:0035966) | 3.33456288 |
| 147 | long-term memory (GO:0007616) | 3.32371913 |
| 148 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.32202121 |
| 149 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.29428327 |
| 150 | membrane depolarization during action potential (GO:0086010) | 3.29375215 |
| 151 | biotin metabolic process (GO:0006768) | 3.28989066 |
| 152 | endocrine pancreas development (GO:0031018) | 3.28629154 |
| 153 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.26975010 |
| 154 | peptidyl-asparagine modification (GO:0018196) | 3.24873906 |
| 155 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.24730315 |
| 156 | regulation of heat generation (GO:0031650) | 3.23734970 |
| 157 | presynaptic membrane organization (GO:0097090) | 3.22482910 |
| 158 | dendritic spine organization (GO:0097061) | 3.21931345 |
| 159 | neuromuscular process controlling posture (GO:0050884) | 3.21555661 |
| 160 | membrane depolarization (GO:0051899) | 3.18473396 |
| 161 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.17393094 |
| 162 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.15839644 |
| 163 | mitochondrion transport along microtubule (GO:0047497) | 3.15839644 |
| 164 | sulfur amino acid biosynthetic process (GO:0000097) | 3.15489713 |
| 165 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.14570805 |
| 166 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13251379 |
| 167 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.12843993 |
| 168 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.12390096 |
| 169 | neuromuscular synaptic transmission (GO:0007274) | 3.11447671 |
| 170 | cholesterol transport (GO:0030301) | 3.09386013 |
| 171 | sterol transport (GO:0015918) | 3.09386013 |
| 172 | lysine metabolic process (GO:0006553) | 3.06884201 |
| 173 | lysine catabolic process (GO:0006554) | 3.06884201 |
| 174 | acid secretion (GO:0046717) | 3.06423982 |
| 175 | acidic amino acid transport (GO:0015800) | 3.05840147 |
| 176 | glycine transport (GO:0015816) | 3.05727702 |
| 177 | regulation of digestive system process (GO:0044058) | 3.03133260 |
| 178 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.02929739 |
| 179 | regulation of synaptic transmission (GO:0050804) | 3.00878963 |
| 180 | alpha-amino acid biosynthetic process (GO:1901607) | 3.00298816 |
| 181 | response to auditory stimulus (GO:0010996) | 2.99467789 |
| 182 | protein N-linked glycosylation (GO:0006487) | 2.99060681 |
| 183 | glycine metabolic process (GO:0006544) | 2.98460470 |
| 184 | adult walking behavior (GO:0007628) | 2.98144200 |
| 185 | proline transport (GO:0015824) | 2.96824598 |
| 186 | establishment of synaptic vesicle localization (GO:0097480) | 2.96587503 |
| 187 | synaptic vesicle transport (GO:0048489) | 2.96587503 |
| 188 | sulfur amino acid catabolic process (GO:0000098) | 2.96586020 |
| 189 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.96352233 |
| 190 | cerebellar Purkinje cell layer development (GO:0021680) | 2.94407737 |
| 191 | polarized epithelial cell differentiation (GO:0030859) | 2.93566717 |
| 192 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.93234842 |
| 193 | regulation of dendritic spine development (GO:0060998) | 2.92323796 |
| 194 | mating behavior (GO:0007617) | 2.92213011 |
| 195 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.87707457 |
| 196 | intestinal cholesterol absorption (GO:0030299) | 17.9125018 |
| 197 | exocrine pancreas development (GO:0031017) | 16.2552611 |
| 198 | digestion (GO:0007586) | 15.2775683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.85277571 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.55473819 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.34834573 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.96202306 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.60858853 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.32739360 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.29753439 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.01054018 |
| 9 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.98855729 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.93025650 |
| 11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.88709094 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.86352441 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83912575 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.83897845 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.79142480 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.77921809 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.77444052 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77443777 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75611130 |
| 20 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72799822 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.72544226 |
| 22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.71235659 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.67201828 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.57943614 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.56721606 |
| 26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.55867167 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.55867167 |
| 28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55382763 |
| 29 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55204483 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.53288291 |
| 31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.50542254 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.48193103 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.41303361 |
| 34 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.38591143 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.38591143 |
| 36 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.38591143 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.26030913 |
| 38 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.24571054 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24471793 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23762191 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15363360 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15117664 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11713712 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10731005 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.10353272 |
| 46 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 2.09898947 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06763161 |
| 48 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98344701 |
| 49 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.97838032 |
| 50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.96154537 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94371139 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.93115504 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.92085995 |
| 54 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.88270403 |
| 55 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.87597623 |
| 56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82521087 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78587976 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74744828 |
| 59 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.70292327 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67972542 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66548320 |
| 62 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60600162 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60085054 |
| 64 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.59908513 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.59902851 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56527020 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53365439 |
| 68 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.44041677 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43685386 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.42543787 |
| 71 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.42465234 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41951202 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37838091 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37615374 |
| 75 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.36880826 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.33960017 |
| 77 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.33575525 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32697010 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31264466 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29329752 |
| 81 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.28434865 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.27944210 |
| 83 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.27597737 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26870970 |
| 85 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25158724 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25152887 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19957833 |
| 88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19472322 |
| 89 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.15637118 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14249671 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13996622 |
| 92 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12293261 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10775765 |
| 94 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10623266 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.10616449 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10340368 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09436449 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07318194 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.07059111 |
| 100 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06863711 |
| 101 | ERA_21632823_ChIP-Seq_H3396_Human | 1.06400540 |
| 102 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05711179 |
| 103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05501243 |
| 104 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04222585 |
| 105 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04171511 |
| 106 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03984110 |
| 107 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03496066 |
| 108 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03433538 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02748005 |
| 110 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.02730798 |
| 111 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.02392538 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00816266 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00700673 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00590579 |
| 115 | AR_19668381_ChIP-Seq_PC3_Human | 1.00232140 |
| 116 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99373847 |
| 117 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.99083849 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98583576 |
| 119 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98103066 |
| 120 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.97887866 |
| 121 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97626177 |
| 122 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97289957 |
| 123 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96563551 |
| 124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95884498 |
| 125 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.95736841 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95075150 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94898997 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94092264 |
| 129 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94015505 |
| 130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93824722 |
| 131 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93386087 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.93359257 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93353220 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93104767 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92798361 |
| 136 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92183113 |
| 137 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92176329 |
| 138 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91868712 |
| 139 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91810975 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91732843 |
| 141 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.91529660 |
| 142 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.91025087 |
| 143 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.90885252 |
| 144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90450327 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90240586 |
| 146 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89532732 |
| 147 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88809677 |
| 148 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88613577 |
| 149 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.88563907 |
| 150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88544980 |
| 151 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88486772 |
| 152 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88212519 |
| 153 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88062489 |
| 154 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87282529 |
| 155 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87256963 |
| 156 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87064514 |
| 157 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.85893106 |
| 158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85678399 |
| 159 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85300287 |
| 160 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.85212249 |
| 161 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84130488 |
| 162 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84076403 |
| 163 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83473452 |
| 164 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82791450 |
| 165 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82776448 |
| 166 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82328427 |
| 167 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.82217188 |
| 168 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80969741 |
| 169 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80840544 |
| 170 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.80678710 |
| 171 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80531936 |
| 172 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.80436883 |
| 173 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80327001 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80286834 |
| 175 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.79965016 |
| 176 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.79065023 |
| 177 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.77696645 |
| 178 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.77431333 |
| 179 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74904352 |
| 180 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.74646135 |
| 181 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74053952 |
| 182 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73444632 |
| 183 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73269523 |
| 184 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.73170652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 9.68847850 |
| 2 | MP0001666_abnormal_nutrient_absorption | 9.38813293 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 6.43893290 |
| 4 | MP0005365_abnormal_bile_salt | 6.30899684 |
| 5 | MP0005220_abnormal_exocrine_pancreas | 6.03622407 |
| 6 | MP0003868_abnormal_feces_composition | 5.08211505 |
| 7 | MP0003880_abnormal_central_pattern | 4.95953941 |
| 8 | MP0005084_abnormal_gallbladder_morpholo | 4.66060667 |
| 9 | MP0005423_abnormal_somatic_nervous | 4.62117569 |
| 10 | MP0004270_analgesia | 4.23734668 |
| 11 | MP0008004_abnormal_stomach_pH | 4.12240506 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 3.87016161 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 3.51125668 |
| 14 | MP0002064_seizures | 3.43555437 |
| 15 | MP0001664_abnormal_digestion | 3.14678209 |
| 16 | MP0002063_abnormal_learning/memory/cond | 3.09989832 |
| 17 | MP0009745_abnormal_behavioral_response | 3.08091656 |
| 18 | MP0002272_abnormal_nervous_system | 2.93206993 |
| 19 | MP0001486_abnormal_startle_reflex | 2.73368491 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.71959940 |
| 21 | MP0009046_muscle_twitch | 2.62328228 |
| 22 | MP0008569_lethality_at_weaning | 2.49316938 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.46508331 |
| 24 | MP0003959_abnormal_lean_body | 2.42871753 |
| 25 | MP0002693_abnormal_pancreas_physiology | 2.39562679 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.36366831 |
| 27 | MP0003879_abnormal_hair_cell | 2.20150574 |
| 28 | MP0003787_abnormal_imprinting | 2.10890288 |
| 29 | MP0003123_paternal_imprinting | 2.04483607 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.99487878 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.98686941 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.92391640 |
| 33 | MP0001970_abnormal_pain_threshold | 1.88339842 |
| 34 | MP0000920_abnormal_myelination | 1.82868575 |
| 35 | MP0000778_abnormal_nervous_system | 1.82299580 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.81551628 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.80946134 |
| 38 | MP0002822_catalepsy | 1.79064584 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.71406925 |
| 40 | MP0003690_abnormal_glial_cell | 1.68704911 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.68187461 |
| 42 | MP0004264_abnormal_extraembryonic_tissu | 1.67214502 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.65811238 |
| 44 | MP0000470_abnormal_stomach_morphology | 1.63447815 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.62632523 |
| 46 | MP0002067_abnormal_sensory_capabilities | 1.62442549 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.60225735 |
| 48 | MP0000955_abnormal_spinal_cord | 1.59057965 |
| 49 | MP0003122_maternal_imprinting | 1.57392961 |
| 50 | MP0001944_abnormal_pancreas_morphology | 1.57046678 |
| 51 | MP0005448_abnormal_energy_balance | 1.56443486 |
| 52 | MP0003633_abnormal_nervous_system | 1.53388900 |
| 53 | MP0002736_abnormal_nociception_after | 1.52371354 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.51336761 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.49657623 |
| 56 | MP0004885_abnormal_endolymph | 1.49254370 |
| 57 | MP0004233_abnormal_muscle_weight | 1.48300197 |
| 58 | MP0002066_abnormal_motor_capabilities/c | 1.46558609 |
| 59 | MP0001873_stomach_inflammation | 1.44974689 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.37048987 |
| 61 | MP0002184_abnormal_innervation | 1.36932324 |
| 62 | MP0003631_nervous_system_phenotype | 1.36851235 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.34741666 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.33423037 |
| 65 | MP0005165_increased_susceptibility_to | 1.32900471 |
| 66 | MP0003638_abnormal_response/metabolism_ | 1.31086731 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.30370500 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.24325191 |
| 69 | MP0001177_atelectasis | 1.21574485 |
| 70 | MP0002229_neurodegeneration | 1.20090178 |
| 71 | MP0005332_abnormal_amino_acid | 1.19065267 |
| 72 | MP0001984_abnormal_olfaction | 1.15970599 |
| 73 | MP0001905_abnormal_dopamine_level | 1.15763529 |
| 74 | MP0003634_abnormal_glial_cell | 1.15614803 |
| 75 | MP0004742_abnormal_vestibular_system | 1.15382076 |
| 76 | MP0005451_abnormal_body_composition | 1.13947087 |
| 77 | MP0001188_hyperpigmentation | 1.12533207 |
| 78 | MP0002152_abnormal_brain_morphology | 1.11481291 |
| 79 | MP0003632_abnormal_nervous_system | 1.11045999 |
| 80 | MP0003252_abnormal_bile_duct | 1.07528291 |
| 81 | MP0002909_abnormal_adrenal_gland | 1.06727653 |
| 82 | MP0000604_amyloidosis | 1.04781949 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.01839267 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.96831249 |
| 85 | MP0001529_abnormal_vocalization | 0.96739272 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.96537666 |
| 87 | MP0000490_abnormal_crypts_of | 0.95441023 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.93124327 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.92750481 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.90618052 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.88939212 |
| 92 | MP0003121_genomic_imprinting | 0.86721109 |
| 93 | MP0005408_hypopigmentation | 0.86614892 |
| 94 | MP0006054_spinal_hemorrhage | 0.83350918 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.82931964 |
| 96 | MP0001663_abnormal_digestive_system | 0.82764160 |
| 97 | MP0000003_abnormal_adipose_tissue | 0.80248227 |
| 98 | MP0002752_abnormal_somatic_nervous | 0.79757966 |
| 99 | MP0008874_decreased_physiological_sensi | 0.78972802 |
| 100 | MP0004142_abnormal_muscle_tone | 0.77621745 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.77481778 |
| 102 | MP0003186_abnormal_redox_activity | 0.77439947 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 0.76254468 |
| 104 | MP0002928_abnormal_bile_duct | 0.75489755 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.75400176 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 0.75223613 |
| 107 | MP0003953_abnormal_hormone_level | 0.75006628 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.74539323 |
| 109 | MP0005535_abnormal_body_temperature | 0.73876863 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.73830786 |
| 111 | MP0008438_abnormal_cutaneous_collagen | 0.73405652 |
| 112 | MP0005409_darkened_coat_color | 0.73065083 |
| 113 | MP0000566_synostosis | 0.70259540 |
| 114 | MP0005452_abnormal_adipose_tissue | 0.68099303 |
| 115 | MP0006036_abnormal_mitochondrial_physio | 0.65423676 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.64099122 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.62001254 |
| 118 | MP0005058_abnormal_lysosome_morphology | 0.60102831 |
| 119 | MP0000598_abnormal_liver_morphology | 0.59715947 |
| 120 | MP0001346_abnormal_lacrimal_gland | 0.59313726 |
| 121 | MP0001764_abnormal_homeostasis | 0.58916153 |
| 122 | MP0000747_muscle_weakness | 0.57658770 |
| 123 | MP0010769_abnormal_survival | 0.57229169 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.56939786 |
| 125 | MP0003861_abnormal_nervous_system | 0.56674663 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.56422791 |
| 127 | MP0005499_abnormal_olfactory_system | 0.55646011 |
| 128 | MP0005394_taste/olfaction_phenotype | 0.55646011 |
| 129 | MP0002082_postnatal_lethality | 0.54191070 |
| 130 | MP0010770_preweaning_lethality | 0.54191070 |
| 131 | MP0010768_mortality/aging | 0.53957508 |
| 132 | MP0000613_abnormal_salivary_gland | 0.53724565 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.52649453 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.51312106 |
| 135 | MP0005645_abnormal_hypothalamus_physiol | 0.50593315 |
| 136 | MP0000579_abnormal_nail_morphology | 0.50448739 |
| 137 | MP0005360_urolithiasis | 0.50363758 |
| 138 | MP0001943_abnormal_respiration | 0.49716290 |
| 139 | MP0000026_abnormal_inner_ear | 0.49076485 |
| 140 | MP0000609_abnormal_liver_physiology | 0.48399699 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.46814836 |
| 142 | MP0001731_abnormal_postnatal_growth | 0.45611481 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.42666431 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.42522445 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.42470637 |
| 146 | MP0002796_impaired_skin_barrier | 0.42230584 |
| 147 | MP0005334_abnormal_fat_pad | 0.40533520 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.40444314 |
| 149 | MP0005375_adipose_tissue_phenotype | 0.38048557 |
| 150 | MP0002060_abnormal_skin_morphology | 0.37487555 |
| 151 | MP0000750_abnormal_muscle_regeneration | 0.36717675 |
| 152 | MP0000367_abnormal_coat/_hair | 0.36373407 |
| 153 | MP0002876_abnormal_thyroid_physiology | 0.35231292 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.32995444 |
| 155 | MP0003045_fibrosis | 0.32549956 |
| 156 | MP0008872_abnormal_physiological_respon | 0.32190760 |
| 157 | MP0000377_abnormal_hair_follicle | 0.32055718 |
| 158 | MP0003795_abnormal_bone_structure | 0.31536254 |
| 159 | MP0000371_diluted_coat_color | 0.31138066 |
| 160 | MP0005636_abnormal_mineral_homeostasis | 0.30956386 |
| 161 | MP0003283_abnormal_digestive_organ | 0.28232970 |
| 162 | MP0003329_amyloid_beta_deposits | 0.27452524 |
| 163 | MP0009333_abnormal_splenocyte_physiolog | 0.27254288 |
| 164 | MP0002069_abnormal_eating/drinking_beha | 0.27220949 |
| 165 | MP0009780_abnormal_chondrocyte_physiolo | 0.24314097 |
| 166 | MP0003191_abnormal_cellular_cholesterol | 0.24287209 |
| 167 | MP0004147_increased_porphyrin_level | 0.24123380 |
| 168 | MP0002970_abnormal_white_adipose | 0.22793934 |
| 169 | MP0005386_behavior/neurological_phenoty | 0.22028884 |
| 170 | MP0004924_abnormal_behavior | 0.22028884 |
| 171 | MP0009931_abnormal_skin_appearance | 0.21250635 |
| 172 | MP0008469_abnormal_protein_level | 0.21118108 |
| 173 | MP0003956_abnormal_body_size | 0.20797440 |
| 174 | MP0003300_gastrointestinal_ulcer | 0.20178848 |
| 175 | MP0000647_abnormal_sebaceous_gland | 0.20149001 |
| 176 | MP0010678_abnormal_skin_adnexa | 0.19469782 |
| 177 | MP0001756_abnormal_urination | 0.18197157 |
| 178 | MP0001348_abnormal_lacrimal_gland | 0.17207757 |
| 179 | MP0009703_decreased_birth_body | 0.16608506 |
| 180 | MP0001243_abnormal_dermal_layer | 0.16549629 |
| 181 | MP0004130_abnormal_muscle_cell | 0.16477774 |
| 182 | MP0008875_abnormal_xenobiotic_pharmacok | 0.16225155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 8.36230911 |
| 2 | Myokymia (HP:0002411) | 8.16666065 |
| 3 | Fat malabsorption (HP:0002630) | 6.91136063 |
| 4 | Gout (HP:0001997) | 6.85823989 |
| 5 | Focal motor seizures (HP:0011153) | 6.03020035 |
| 6 | Short chin (HP:0000331) | 5.87259269 |
| 7 | Focal seizures (HP:0007359) | 5.74780580 |
| 8 | Decreased subcutaneous fat (HP:0001002) | 5.54112512 |
| 9 | Action tremor (HP:0002345) | 5.10883578 |
| 10 | Abnormality of subcutaneous fat tissue (HP:0001001) | 5.03670143 |
| 11 | Type I diabetes mellitus (HP:0100651) | 4.93574648 |
| 12 | Epileptic encephalopathy (HP:0200134) | 4.91861745 |
| 13 | Ankle clonus (HP:0011448) | 4.90224359 |
| 14 | Exocrine pancreatic insufficiency (HP:0001738) | 4.87528210 |
| 15 | Febrile seizures (HP:0002373) | 4.85775253 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 4.84317678 |
| 17 | Abnormal number of erythroid precursors (HP:0012131) | 4.73661606 |
| 18 | Atonic seizures (HP:0010819) | 4.51849971 |
| 19 | Hypoplasia of the pons (HP:0012110) | 4.51811867 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 4.48346190 |
| 21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.44830621 |
| 22 | Maternal diabetes (HP:0009800) | 4.43660736 |
| 23 | Abnormality of the pons (HP:0007361) | 4.23908777 |
| 24 | Abnormality of binocular vision (HP:0011514) | 4.20502197 |
| 25 | Diplopia (HP:0000651) | 4.20502197 |
| 26 | Limb dystonia (HP:0002451) | 4.15650428 |
| 27 | Neurofibrillary tangles (HP:0002185) | 4.11265317 |
| 28 | Tubulointerstitial nephritis (HP:0001970) | 4.06231818 |
| 29 | Spastic gait (HP:0002064) | 4.04658711 |
| 30 | Visual hallucinations (HP:0002367) | 4.03250031 |
| 31 | Pancreatitis (HP:0001733) | 3.88585170 |
| 32 | Abnormal pancreas size (HP:0012094) | 3.88160490 |
| 33 | Cortical dysplasia (HP:0002539) | 3.82013046 |
| 34 | Premature skin wrinkling (HP:0100678) | 3.80100691 |
| 35 | Annular pancreas (HP:0001734) | 3.79354847 |
| 36 | Ketosis (HP:0001946) | 3.78180700 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.72143130 |
| 38 | Cerebral hypomyelination (HP:0006808) | 3.69746067 |
| 39 | Tubulointerstitial fibrosis (HP:0005576) | 3.62293697 |
| 40 | Abnormal eating behavior (HP:0100738) | 3.58379404 |
| 41 | Torticollis (HP:0000473) | 3.56632501 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 3.53595451 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 3.53562624 |
| 44 | Ketoacidosis (HP:0001993) | 3.52667390 |
| 45 | Generalized tonic-clonic seizures (HP:0002069) | 3.52294340 |
| 46 | Joint stiffness (HP:0001387) | 3.49703779 |
| 47 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.46267747 |
| 48 | Dysmetria (HP:0001310) | 3.45482073 |
| 49 | Mutism (HP:0002300) | 3.32641558 |
| 50 | Hypoproteinemia (HP:0003075) | 3.32585771 |
| 51 | Carpal bone hypoplasia (HP:0001498) | 3.32295971 |
| 52 | Hyperglycinemia (HP:0002154) | 3.22911112 |
| 53 | Postural instability (HP:0002172) | 3.22829975 |
| 54 | Cerebral inclusion bodies (HP:0100314) | 3.22433078 |
| 55 | Obstructive sleep apnea (HP:0002870) | 3.20772025 |
| 56 | Hyperuricemia (HP:0002149) | 3.18883702 |
| 57 | Increased purine levels (HP:0004368) | 3.18883702 |
| 58 | Long foot (HP:0001833) | 3.16198225 |
| 59 | Intention tremor (HP:0002080) | 3.12321567 |
| 60 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.11188216 |
| 61 | Megaloblastic anemia (HP:0001889) | 3.07645120 |
| 62 | Akinesia (HP:0002304) | 3.01625572 |
| 63 | Absence seizures (HP:0002121) | 2.99988861 |
| 64 | Focal dystonia (HP:0004373) | 2.99708638 |
| 65 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.98187151 |
| 66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.98187151 |
| 67 | Status epilepticus (HP:0002133) | 2.94971163 |
| 68 | Tetraplegia (HP:0002445) | 2.94782196 |
| 69 | Urinary urgency (HP:0000012) | 2.90642171 |
| 70 | Dialeptic seizures (HP:0011146) | 2.88801187 |
| 71 | Truncal ataxia (HP:0002078) | 2.88664561 |
| 72 | Depression (HP:0000716) | 2.87970200 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.86817053 |
| 74 | Hyperglycinuria (HP:0003108) | 2.82808020 |
| 75 | Craniofacial dystonia (HP:0012179) | 2.79848581 |
| 76 | Epileptiform EEG discharges (HP:0011182) | 2.76486192 |
| 77 | Poor eye contact (HP:0000817) | 2.75173476 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.74907600 |
| 79 | Abnormality of the common coagulation pathway (HP:0010990) | 2.73969615 |
| 80 | Hypoglycemic coma (HP:0001325) | 2.73389224 |
| 81 | Hemiplegia (HP:0002301) | 2.71292698 |
| 82 | Clonus (HP:0002169) | 2.69988059 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.69163987 |
| 84 | Abnormality of glycine metabolism (HP:0010895) | 2.68381755 |
| 85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.68381755 |
| 86 | Papilledema (HP:0001085) | 2.68035377 |
| 87 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.67243382 |
| 88 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.67243382 |
| 89 | Insomnia (HP:0100785) | 2.66665277 |
| 90 | Anxiety (HP:0000739) | 2.66055998 |
| 91 | Ventricular fibrillation (HP:0001663) | 2.65360821 |
| 92 | Abnormal tarsal ossification (HP:0008369) | 2.65062228 |
| 93 | Prenatal maternal abnormality (HP:0002686) | 2.60259348 |
| 94 | Abnormality of the lower motor neuron (HP:0002366) | 2.57638537 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.56441928 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.56441928 |
| 97 | Abnormal protein glycosylation (HP:0012346) | 2.56441928 |
| 98 | Abnormal glycosylation (HP:0012345) | 2.56441928 |
| 99 | Bradykinesia (HP:0002067) | 2.56023658 |
| 100 | Sleep apnea (HP:0010535) | 2.52974272 |
| 101 | EEG with generalized epileptiform discharges (HP:0011198) | 2.52771671 |
| 102 | Optic nerve hypoplasia (HP:0000609) | 2.52761566 |
| 103 | Impaired smooth pursuit (HP:0007772) | 2.52257970 |
| 104 | CNS hypomyelination (HP:0003429) | 2.49405298 |
| 105 | Peripheral hypomyelination (HP:0007182) | 2.48504391 |
| 106 | Fatigue (HP:0012378) | 2.48098523 |
| 107 | Impaired social interactions (HP:0000735) | 2.42767089 |
| 108 | Abnormal social behavior (HP:0012433) | 2.42767089 |
| 109 | Hypsarrhythmia (HP:0002521) | 2.41343601 |
| 110 | Scanning speech (HP:0002168) | 2.41157604 |
| 111 | Delusions (HP:0000746) | 2.39437314 |
| 112 | Fetal akinesia sequence (HP:0001989) | 2.38456753 |
| 113 | Apathy (HP:0000741) | 2.38255600 |
| 114 | Progressive muscle weakness (HP:0003323) | 2.36076487 |
| 115 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.35785095 |
| 116 | Amblyopia (HP:0000646) | 2.34138823 |
| 117 | Tubular atrophy (HP:0000092) | 2.33822017 |
| 118 | Small epiphyses (HP:0010585) | 2.28922349 |
| 119 | Hemiparesis (HP:0001269) | 2.28537926 |
| 120 | Impaired vibratory sensation (HP:0002495) | 2.27736612 |
| 121 | Polyphagia (HP:0002591) | 2.27621836 |
| 122 | Abnormality of vitamin B metabolism (HP:0004340) | 2.27533893 |
| 123 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.27496401 |
| 124 | Spastic tetraparesis (HP:0001285) | 2.26826946 |
| 125 | Choreoathetosis (HP:0001266) | 2.25465607 |
| 126 | Late onset (HP:0003584) | 2.24786217 |
| 127 | Acute hepatic failure (HP:0006554) | 2.23094036 |
| 128 | Dysdiadochokinesis (HP:0002075) | 2.22941747 |
| 129 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.22251128 |
| 130 | Pectus carinatum (HP:0000768) | 2.22223724 |
| 131 | Abnormality of the renal cortex (HP:0011035) | 2.22205749 |
| 132 | Rigidity (HP:0002063) | 2.21444393 |
| 133 | Hypoglycemic seizures (HP:0002173) | 2.20480696 |
| 134 | Abnormality of methionine metabolism (HP:0010901) | 2.18975921 |
| 135 | Reduced antithrombin III activity (HP:0001976) | 2.18416928 |
| 136 | Cortical visual impairment (HP:0100704) | 2.17893294 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 2.17713232 |
| 138 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.17667600 |
| 139 | Hypoplasia of the odontoid process (HP:0003311) | 2.16985578 |
| 140 | Diminished motivation (HP:0000745) | 2.15598376 |
| 141 | Right ventricular cardiomyopathy (HP:0011663) | 2.14849682 |
| 142 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.14193975 |
| 143 | Stereotypic behavior (HP:0000733) | 2.13767890 |
| 144 | Rapidly progressive (HP:0003678) | 2.13650500 |
| 145 | Turricephaly (HP:0000262) | 2.11659293 |
| 146 | Barrel-shaped chest (HP:0001552) | 2.08980009 |
| 147 | Methylmalonic aciduria (HP:0012120) | 2.08978246 |
| 148 | Abnormality of purine metabolism (HP:0004352) | 2.08459274 |
| 149 | Tubulointerstitial abnormality (HP:0001969) | 2.07685499 |
| 150 | Opisthotonus (HP:0002179) | 2.07678051 |
| 151 | Congenital glaucoma (HP:0001087) | 2.07120003 |
| 152 | Genetic anticipation (HP:0003743) | 2.05509619 |
| 153 | Hand muscle atrophy (HP:0009130) | 2.05400329 |
| 154 | Prolonged QT interval (HP:0001657) | 2.03718219 |
| 155 | Renal salt wasting (HP:0000127) | 2.02070289 |
| 156 | Type II lissencephaly (HP:0007260) | 2.01789318 |
| 157 | Abnormality of homocysteine metabolism (HP:0010919) | 1.99669992 |
| 158 | Homocystinuria (HP:0002156) | 1.99669992 |
| 159 | Esophageal varix (HP:0002040) | 1.98980896 |
| 160 | Myocardial infarction (HP:0001658) | 1.95936252 |
| 161 | Incomplete penetrance (HP:0003829) | 1.95409797 |
| 162 | Broad-based gait (HP:0002136) | 1.95315128 |
| 163 | Abnormal foot bone ossification (HP:0010675) | 1.94805995 |
| 164 | Ankyloglossia (HP:0010296) | 1.94181562 |
| 165 | Spinal canal stenosis (HP:0003416) | 1.93030132 |
| 166 | Distal upper limb amyotrophy (HP:0007149) | 1.92829957 |
| 167 | Upper limb amyotrophy (HP:0009129) | 1.92829957 |
| 168 | Dysostosis multiplex (HP:0000943) | 1.92761172 |
| 169 | Pointed chin (HP:0000307) | 1.92431237 |
| 170 | Megalencephaly (HP:0001355) | 1.90961475 |
| 171 | Hyperammonemia (HP:0001987) | 1.90948195 |
| 172 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.90785070 |
| 173 | Acute encephalopathy (HP:0006846) | 1.90642696 |
| 174 | Large hands (HP:0001176) | 1.89912611 |
| 175 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.89159447 |
| 176 | Aplasia of the phalanges of the hand (HP:0009802) | 1.89159447 |
| 177 | Aplasia involving bones of the extremities (HP:0009825) | 1.89159447 |
| 178 | Drooling (HP:0002307) | 1.89129001 |
| 179 | Abnormality of vitamin metabolism (HP:0100508) | 1.87031098 |
| 180 | Hypoplasia of the uterus (HP:0000013) | 1.86073806 |
| 181 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.85686178 |
| 182 | Thickened helices (HP:0000391) | 1.83629388 |
| 183 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.83231946 |
| 184 | Dicarboxylic aciduria (HP:0003215) | 1.83231946 |
| 185 | Bundle branch block (HP:0011710) | 1.82245797 |
| 186 | Thoracic kyphosis (HP:0002942) | 1.81584560 |
| 187 | Lethargy (HP:0001254) | 1.80580851 |
| 188 | Lower limb amyotrophy (HP:0007210) | 1.80208708 |
| 189 | Glomerulosclerosis (HP:0000096) | 1.80014757 |
| 190 | Paraplegia (HP:0010550) | 1.79762850 |
| 191 | Beaking of vertebral bodies (HP:0004568) | 1.79593324 |
| 192 | Cerebral edema (HP:0002181) | 1.79574489 |
| 193 | Limb hypertonia (HP:0002509) | 1.78799795 |
| 194 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74944126 |
| 195 | Abnormality of the odontoid process (HP:0003310) | 1.73576706 |
| 196 | Redundant skin (HP:0001582) | 1.72026066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.25101402 |
| 2 | EIF2AK3 | 4.52149528 |
| 3 | NTRK3 | 4.15921005 |
| 4 | EPHA4 | 4.11732926 |
| 5 | MAP2K2 | 4.03008885 |
| 6 | MARK1 | 3.82742685 |
| 7 | PAK6 | 3.74584698 |
| 8 | TRIB3 | 3.51492140 |
| 9 | PKN2 | 3.26295023 |
| 10 | UHMK1 | 3.00890810 |
| 11 | NTRK2 | 2.70701691 |
| 12 | PRKD3 | 2.39973831 |
| 13 | MINK1 | 2.33346588 |
| 14 | FRK | 2.27674250 |
| 15 | MAPKAPK3 | 2.17676395 |
| 16 | ZAP70 | 2.15057209 |
| 17 | INSRR | 2.10540001 |
| 18 | BCKDK | 10.1663358 |
| 19 | CASK | 1.87964179 |
| 20 | MAP2K1 | 1.73733027 |
| 21 | NME2 | 1.67574529 |
| 22 | ARAF | 1.66794239 |
| 23 | IRAK3 | 1.65446979 |
| 24 | PAK2 | 1.61650087 |
| 25 | CDK5 | 1.60157457 |
| 26 | SGK223 | 1.56667595 |
| 27 | SGK494 | 1.56667595 |
| 28 | SCYL2 | 1.54279708 |
| 29 | PRPF4B | 1.54055939 |
| 30 | NME1 | 1.50884751 |
| 31 | SIK2 | 1.47531886 |
| 32 | TAOK3 | 1.45976659 |
| 33 | TYRO3 | 1.45947313 |
| 34 | PHKG2 | 1.41785783 |
| 35 | PHKG1 | 1.41785783 |
| 36 | WNK4 | 1.39866665 |
| 37 | EEF2K | 1.34833721 |
| 38 | MARK2 | 1.34416096 |
| 39 | PIK3CG | 1.34013959 |
| 40 | GRK5 | 1.29848104 |
| 41 | MAPK13 | 1.29520563 |
| 42 | RPS6KB2 | 1.27501058 |
| 43 | CAMK1 | 1.27163145 |
| 44 | PLK2 | 1.24451530 |
| 45 | PDGFRB | 1.21313801 |
| 46 | DYRK1A | 1.21051344 |
| 47 | PRKCG | 1.19878378 |
| 48 | PAK3 | 1.18242483 |
| 49 | CDK15 | 1.18034140 |
| 50 | CAMK2B | 1.16905821 |
| 51 | LATS2 | 1.15960329 |
| 52 | CDK18 | 1.13149538 |
| 53 | CDK11A | 1.09886533 |
| 54 | FLT3 | 1.09845165 |
| 55 | PIK3CA | 1.08492683 |
| 56 | PTK6 | 1.07673022 |
| 57 | MAPK15 | 1.07060530 |
| 58 | CDK14 | 1.04132645 |
| 59 | DAPK1 | 1.03174411 |
| 60 | SGK2 | 0.99326225 |
| 61 | PDK2 | 0.98301834 |
| 62 | PKN1 | 0.97339883 |
| 63 | SGK3 | 0.93397493 |
| 64 | STK38 | 0.93271673 |
| 65 | BRAF | 0.93191486 |
| 66 | CAMK2G | 0.91104041 |
| 67 | ALK | 0.88724564 |
| 68 | STK11 | 0.86579898 |
| 69 | CAMKK1 | 0.83292515 |
| 70 | WNK1 | 0.83062028 |
| 71 | SIK1 | 0.82320008 |
| 72 | MAP3K13 | 0.80600984 |
| 73 | CAMK2A | 0.79215031 |
| 74 | LRRK2 | 0.78169274 |
| 75 | LATS1 | 0.78043665 |
| 76 | FGFR2 | 0.76270737 |
| 77 | BRSK1 | 0.75785191 |
| 78 | MAP2K6 | 0.75013908 |
| 79 | DAPK2 | 0.74483007 |
| 80 | STK39 | 0.74121893 |
| 81 | MAP3K11 | 0.74054981 |
| 82 | SGK1 | 0.72324800 |
| 83 | LIMK1 | 0.72270040 |
| 84 | MST1R | 0.71491385 |
| 85 | MAP3K2 | 0.70141135 |
| 86 | MAPK10 | 0.67533363 |
| 87 | TNK2 | 0.67301518 |
| 88 | ICK | 0.66778125 |
| 89 | PRKCI | 0.64452198 |
| 90 | MTOR | 0.63004965 |
| 91 | IRAK2 | 0.61893291 |
| 92 | OXSR1 | 0.61776452 |
| 93 | CAMK1G | 0.61292865 |
| 94 | RET | 0.61184344 |
| 95 | MAP3K4 | 0.59145497 |
| 96 | CAMK4 | 0.58955463 |
| 97 | PDPK1 | 0.57824630 |
| 98 | DYRK1B | 0.57633587 |
| 99 | RIPK4 | 0.56986762 |
| 100 | RPS6KA3 | 0.56319335 |
| 101 | MAPK12 | 0.55792487 |
| 102 | CAMK2D | 0.53574251 |
| 103 | TESK1 | 0.52582382 |
| 104 | RPS6KB1 | 0.51103794 |
| 105 | EIF2AK1 | 0.50714210 |
| 106 | CAMKK2 | 0.48496338 |
| 107 | KSR2 | 0.48253110 |
| 108 | MAP2K7 | 0.47520918 |
| 109 | PRKCZ | 0.47023487 |
| 110 | PDK1 | 0.46648500 |
| 111 | KSR1 | 0.45638350 |
| 112 | MET | 0.41477671 |
| 113 | PRKG2 | 0.40910961 |
| 114 | ROCK2 | 0.40144015 |
| 115 | IRAK4 | 0.40061695 |
| 116 | PRKAA1 | 0.37059500 |
| 117 | FYN | 0.36356075 |
| 118 | PINK1 | 0.35248350 |
| 119 | ERBB2 | 0.35116488 |
| 120 | PDK4 | 0.34159133 |
| 121 | PDK3 | 0.34159133 |
| 122 | MAPK8 | 0.33746712 |
| 123 | PRKACB | 0.33633888 |
| 124 | PRKCH | 0.32889967 |
| 125 | MAPK3 | 0.32212082 |
| 126 | NEK6 | 0.32049421 |
| 127 | PRKCA | 0.31793108 |
| 128 | RPS6KA1 | 0.31100614 |
| 129 | ILK | 0.30317515 |
| 130 | JAK2 | 0.30282295 |
| 131 | MAP3K9 | 0.29378893 |
| 132 | RAF1 | 0.28977960 |
| 133 | CSNK1G2 | 0.28542836 |
| 134 | CDK19 | 0.27699175 |
| 135 | FER | 0.27325908 |
| 136 | NTRK1 | 0.26128342 |
| 137 | MAP3K7 | 0.26126689 |
| 138 | MAP3K8 | 0.25947032 |
| 139 | MAPK11 | 0.24526074 |
| 140 | MAP3K3 | 0.22743036 |
| 141 | ABL1 | 0.22115380 |
| 142 | RIPK1 | 0.21701113 |
| 143 | TBK1 | 0.19919749 |
| 144 | EPHB1 | 0.19819206 |
| 145 | DDR2 | 0.19611558 |
| 146 | MAP3K1 | 0.19076890 |
| 147 | PTK2 | 0.16752052 |
| 148 | MAPK1 | 0.15434407 |
| 149 | IRAK1 | 0.14833864 |
| 150 | IGF1R | 0.14516198 |
| 151 | DYRK2 | 0.14420862 |
| 152 | PRKD1 | 0.13472222 |
| 153 | PDGFRA | 0.12981474 |
| 154 | MAP2K4 | 0.12920829 |
| 155 | MATK | 0.12407266 |
| 156 | EGFR | 0.12374969 |
| 157 | PIM2 | 0.11555905 |
| 158 | AKT1 | 0.10449615 |
| 159 | STK16 | 0.10232218 |
| 160 | LMTK2 | 0.09093167 |
| 161 | DAPK3 | 0.08914621 |
| 162 | NUAK1 | 0.08777094 |
| 163 | RPS6KA2 | 0.06619721 |
| 164 | CSNK1E | 0.05851437 |
| 165 | FGFR4 | 0.05455256 |
| 166 | CSNK1A1 | 0.05407656 |
| 167 | CAMK1D | 0.04874981 |
| 168 | MAPKAPK5 | 0.04777412 |
| 169 | BMX | 0.04577250 |
| 170 | MAP2K3 | 0.04312674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 8.29833447 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 6.39253706 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.34184457 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.86330570 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76222718 |
| 6 | Protein export_Homo sapiens_hsa03060 | 3.17570112 |
| 7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.00626682 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.79214126 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.78086666 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.54343392 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.51348922 |
| 12 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.48785882 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.48214120 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41459979 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38014850 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.37174447 |
| 17 | Circadian entrainment_Homo sapiens_hsa04713 | 2.35061639 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 2.28802466 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26978932 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.24982484 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.10707842 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03112677 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93665677 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91395290 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.78984439 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71161906 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65516170 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56447759 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55473353 |
| 30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50670057 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.43023317 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40713310 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37875146 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34957291 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29686971 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27337754 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25501486 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.22497147 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.19328236 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.15718340 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09321313 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.09049416 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08439989 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06785608 |
| 45 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02448095 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00911279 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98895073 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98072033 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94382458 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.93714016 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.93005233 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89874782 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.87393853 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.84116284 |
| 55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84114626 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.84015012 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83817189 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83660522 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82933798 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81498001 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.78436264 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78017745 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77275108 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77068321 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75219543 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75055063 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72303614 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71576995 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71069671 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.70445950 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70269644 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.70203018 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69600459 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68966326 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67833149 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66238842 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65704972 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65646240 |
| 79 | Prion diseases_Homo sapiens_hsa05020 | 0.65613007 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65263314 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64850009 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64630381 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63672690 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63128580 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62937337 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61371853 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61098257 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60692689 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59112260 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58445195 |
| 91 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58225785 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57722661 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56219050 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55708327 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.55623962 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55034060 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54692159 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.52984713 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52260800 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51728195 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51670869 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.51330843 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49734959 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48787304 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47979447 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46433602 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45488314 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43961302 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42185266 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39162970 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38795952 |
| 112 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38629358 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.38447323 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37291021 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36713566 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.36008108 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34569537 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34398776 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33928178 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33654497 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33458399 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33445647 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33177938 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33072547 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.32831292 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32286622 |
| 127 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32180780 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.29887267 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29864230 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29490727 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29339972 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28934628 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28517190 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.27308150 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27234932 |
| 136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26310718 |
| 137 | Tight junction_Homo sapiens_hsa04530 | 0.25959423 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21441119 |
| 139 | Lysosome_Homo sapiens_hsa04142 | 0.21415049 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20221672 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.19145943 |
| 142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.18541492 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.16826642 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13706587 |
| 145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13285868 |
| 146 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12548618 |
| 147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10901195 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.09275671 |
| 149 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09175763 |
| 150 | Histidine metabolism_Homo sapiens_hsa00340 | 0.09158535 |
| 151 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.08945222 |
| 152 | Bile secretion_Homo sapiens_hsa04976 | 0.08706835 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05390052 |
| 154 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.02961812 |
| 155 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.02690592 |
| 156 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.02445139 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.02072956 |
| 158 | Ribosome_Homo sapiens_hsa03010 | 0.01931929 |
| 159 | Insulin resistance_Homo sapiens_hsa04931 | 0.01405624 |
| 160 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.00768747 |
| 161 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0134671 |
| 162 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0077326 |
| 163 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0035248 |

